quarta-feira, 7 de outubro de 2026
PesquisarExplore
pt.VIA.NEWS
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· February 3, 2026

Snowflake Makes Enterprise Data AI-Ready With Snowflake Postgres and Advanced Innovations for Open Data Interoperability

View original at finance.yahoo.com
Snowflake Makes Enterprise Data AI-Ready With Snowflake Postgres and Advanced Innovations for Open Data Interoperability Snowflake Postgres unifies the world’s most popular database with analytics and AI on a single, secure platformSnowflake Horizon Catalog provides enterprises with seamless interoperability, centraliz…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • With Snowflake Postgres, BlueCloud can deliver low-latency transactional workloads alongside analytics and AI on a single platform, reducing overhead and helping customers be more agile

    80% confidence

  • Eliminating data silos, fragile pipelines, and closed systems is necessary to speed up AI deployment and reduce risk

    80% confidence

  • PostgreSQL is the world's most popular database

    80% confidence

  • Snowflake Postgres gives teams and customers a simpler, more reliable foundation to build governed analytics and AI-powered experiences that respond in real time

    80% confidence

  • Sigma Computing customers expect live, interactive analytics on the most current business data

    80% confidence

  • With Snowflake Postgres, Sigma Computing can work directly on fresh transactional data inside Snowflake without relying on complex pipelines or external systems

    80% confidence

  • Snowflake Postgres eliminates pipelines by bringing transactional, analytical, and AI capabilities together on a single, enterprise-ready platform

    80% confidence

  • As businesses move from AI experimentation to production, the real challenge is ensuring AI systems can consistently access data that is connected, governed, and discoverable across the enterprise

    80% confidence

  • Snowflake Postgres represents a major opportunity to help BlueCloud customers eliminate data pipelines without compromising performance

    80% confidence

  • Most organizations still keep their transactional and analytical databases siloed on separate systems, forcing teams to rely on complex pipelines

    80% confidence

  • Snowflake Postgres's enterprise-grade Postgres foundation brings real credibility, particularly for financial services organizations

    80% confidence

  • By bringing unified operational and analytical data and open interoperability together in one platform, Snowflake is empowering customers to develop enterprise-ready AI systems that work with real business data, securely and at scale

    80% confidence
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,986
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,986 factos verificados com a fonte5,362 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
Snowflake Makes Enterprise Data AI-Ready With Snowflake Postgres and Advanced Innovations for Open Data Interoperability — Source | Via News | pt.VIA.NEWS